Home » Topics » BioWorld Science

BioWorld Science
RSS

KW-6356 affects motor scores in phase II early Parkinson's disease trial

Aug. 24, 2018

Wee1 is a target in rhabdomyosarcoma

Aug. 24, 2018

Gene therapy for dominant blindness

Aug. 24, 2018

Phase III SOLAR-1 study of BYL-719 in breast cancer meets PFS primary endpoint

Aug. 23, 2018

AbbVie reports topline results from phase III extension study with elagolix for uterine fibroids

Aug. 23, 2018

Impel initiates phase III study of INP-104 for migraine

Aug. 23, 2018

Nuevolution reveals lead discovery program targeting inhibition of IL-17A using small molecules

Aug. 23, 2018

FDA approves Oxervate for neurotrophic keratitis

Aug. 23, 2018

UP Therapeutics identifies proteasome inhibitors

Aug. 23, 2018

Jupiter Orphan Therapeutics announces favorable Jotrol preclinical data

Aug. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...